Access to the PPM Journal and newsletters is FREE for clinicians.

Opioid-Selling Websites Warned

June 6, 2018
FDA issues Warning Letters to 53 companies selling or marketing tramadol, oxycodone, and other opioids illegally.

A PPM Brief

The US FDA has issued Warning Letters to the owners of 53 websites across nine online networks to stop “illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications”—specifically including tramadol and oxycodone which carry boxed warnings, according to an agency release. Companies (see list below) who fail to correct the violations may be subject to an injunction or product seizure.

Commissioner Scott Gottlieb, MD, said the agency is determined to “protect US consumers from illicit opioids…. The internet is virtually awash in illegal narcotics and we’re going to be taking new steps to work with legitimate Internet firms to voluntarily crack down on these sales.”

Added Donald D. Ashley, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research, "The public needs to know that no one is authorized to sell or distribute opioids via the Internet in the US, with or without a prescription.”

On June 27, an FDA hosted Online Opioid Summit will bring online stakeholders together to collaboratively discuss these issues, he added. Topics will address “research into the ease with which illicit opioids can be purchased online and industry approaches to addressing opioids marketed online, followed by a roundtable discussion to identify gaps and new solutions,” according to the release.

Warning Letters were sent to the following:


Last updated on: June 7, 2018
Continue Reading:
FDA, FTC Send Warning over Illegal Opioid Cessation Products
close X